Neurophysiology for predicting good and poor neurological outcome at 12 and 72 h after cardiac arrest: The ProNeCA multicentre prospective study.

Anoxia-ischemia Brain Cardiac arrest Coma Electroencephalogram Prognosis Somatosensory evoked potentials

Journal

Resuscitation
ISSN: 1873-1570
Titre abrégé: Resuscitation
Pays: Ireland
ID NLM: 0332173

Informations de publication

Date de publication:
01 02 2020
Historique:
received: 11 09 2019
revised: 30 10 2019
accepted: 06 11 2019
pubmed: 4 12 2019
medline: 26 5 2021
entrez: 3 12 2019
Statut: ppublish

Résumé

To assess the accuracy of electroencephalogram (EEG) and somatosensory evoked potentials (SEPs) recorded at 12 and 72 h from resuscitation for predicting six-months neurological outcome in patients who are comatose after cardiac arrest. Prospective multicentre prognostication study. EEG was classified according to the American Clinical Neurophysiology Society terminology. SEPs were graded according to the presence and amplitude of their cortical responses. Neurological outcome was defined as good (cerebral performance categories [CPC] 1-3) vs. poor (CPC 4-5). None of the patients underwent withdrawal of life-sustaining treatment. A total of 351 patients were included, of whom 134 (38%) had good neurological outcome. At 12 h, a continuous, nearly continuous and low-voltage EEG pattern predicted good neurological outcome with 71[61-80]% sensitivity, while an isoelectric EEG and a bilaterally absent/absent-pathological amplitude (AA/AP) cortical SEP pattern predicted poor neurological outcome with 14[8-21]% and 59[50-68]% sensitivity, respectively. Specificity was 100[97-100]% for all predictors. At 72 h, both an isoelectric, suppression or burst-suppression pattern on EEG and an AA/AP SEP pattern predicted poor outcome with 100[97-100]% specificity. Their sensitivities were 63[55-70]% and 66[58-74]%, respectively. When EEG and SEPs were combined, sensitivity for poor outcome prediction increased to 79%. In comatose resuscitated patients, EEG and SEPs predicted good and poor neurological outcome respectively, with 100% specificity as early as 12 h after cardiac arrest. At 72 h after arrest, unfavourable EEG and SEP patterns predicted poor neurological outcome with 100% specificity and high sensitivity, which further increased after their combination.

Identifiants

pubmed: 31790754
pii: S0300-9572(19)30705-1
doi: 10.1016/j.resuscitation.2019.11.014
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

95-103

Investigateurs

Angelo Zilioli (A)
Aldo Amantini (A)
Daniela Audenino (D)
Chiara Bandinelli (C)
Pasquale Bernardo (P)
Teresa Anna Cantisani (TA)
Riccardo Carrai (R)
Maria Grazia Celani (MG)
Roberta Ciuffini (R)
Sara Contardi (S)
Leonardo Davì (L)
Antonello Grippo (A)
Giovanni Lanzo (G)
Francesco Lolli (F)
Maria Lombardi (M)
Alfonso Marrelli (A)
Andrea Marudi (A)
Oriano Mecarelli (O)
Chiara Minardi (C)
Fabio Minicucci (F)
Marco Moretti (M)
Giuseppe Olivo (G)
Adriano Peris (A)
Lucia Politini (L)
Klaudio Rikani (K)
Rossella Sabadini (R)
Claudio Sandroni (C)
Maenia Scarpino (M)
Maddalena Spalletti (M)
Franco Valzania (F)
Eugenio Vitelli (E)
Angelo Zilioli (A)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Maenia Scarpino (M)

IRCCS Fondazione Don Carlo Gnocchi, Firenze, Italy; SODc Neurofisiopatologia, Dipartimento Neuromuscolo-Scheletrico e degli Organi di Senso, AOU Careggi, Firenze, Italy.

Riccardo Carrai (R)

IRCCS Fondazione Don Carlo Gnocchi, Firenze, Italy; SODc Neurofisiopatologia, Dipartimento Neuromuscolo-Scheletrico e degli Organi di Senso, AOU Careggi, Firenze, Italy.

Francesco Lolli (F)

Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università degli Studi di Firenze, Italy.

Giovanni Lanzo (G)

SODc Neurofisiopatologia, Dipartimento Neuromuscolo-Scheletrico e degli Organi di Senso, AOU Careggi, Firenze, Italy.

Maddalena Spalletti (M)

SODc Neurofisiopatologia, Dipartimento Neuromuscolo-Scheletrico e degli Organi di Senso, AOU Careggi, Firenze, Italy.

Franco Valzania (F)

Neurological Unit, Arcispedale S. Maria Nuova, AUSL-IRCCS, Reggio Emilia, Italy.

Maria Lombardi (M)

UO Neurologia, Ospedale San Giuseppe, Empoli, Italy.

Daniela Audenino (D)

SC Neurologia, Ospedale Galliera, Genova, Italy.

Sara Contardi (S)

Neurofisiopatologia Interventiva, Ospedale Civile di Baggiovara, Modena, Italy.

Maria Grazia Celani (MG)

UO Neurofisiopatologia, Ospedale Santa Maria della Misericordia, Perugia, Italy.

Alfonso Marrelli (A)

UOC Neurofisiopatologia, Ospedale San Salvatore, L' Aquila, Italy.

Oriano Mecarelli (O)

UOC Neurofisiopatologia, Azienda Ospedaliero Universitaria Policlinico Umberto Primo, Roma, Italy.

Chiara Minardi (C)

UO Neurologia, Ospedale Bufalini, Cesena, Italy.

Fabio Minicucci (F)

UO Neurofisiopatologia, Ospedale San Raffaele IRCCS, Milano, Italy.

Lucia Politini (L)

Ospedale Civile, Legnano, Italy.

Eugenio Vitelli (E)

Ospedale Maggiore, Lodi, Italy.

Adriano Peris (A)

SODc Cure intensive per il Trauma ed i Supporti Extracorporei, Dipartimento Neuromuscolo-Scheletrico e degli Organi di Senso, AOU Careggi, Firenze, Italy.

Aldo Amantini (A)

IRCCS Fondazione Don Carlo Gnocchi, Firenze, Italy; SODc Neurofisiopatologia, Dipartimento Neuromuscolo-Scheletrico e degli Organi di Senso, AOU Careggi, Firenze, Italy.

Claudio Sandroni (C)

Istituto Anestesiologia e Rianimazione Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario "Agostino Gemelli", IRCCS, Largo Gemelli, 8, 00168 Rome, Italy. Electronic address: claudio.sandroni@policlinicogemelli.it.

Antonello Grippo (A)

IRCCS Fondazione Don Carlo Gnocchi, Firenze, Italy; SODc Neurofisiopatologia, Dipartimento Neuromuscolo-Scheletrico e degli Organi di Senso, AOU Careggi, Firenze, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH